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The IkB kinase complex induces nuclear factor kappa B activation and has recently been recognized as a key player of auto-
immunity in the central nervous system. Notably, IkB kinase/nuclear factor kappa B signalling regulates peripheral myelin
formation by Schwann cells, however, its role in myelin formation in the central nervous system during health and disease is
largely unknown. Surprisingly, we found that brain-specific IkB kinase 2 expression is dispensable for proper myelin assembly
and repair in the central nervous system, but instead plays a fundamental role for the loss of myelin in the cuprizone model.
During toxic demyelination, inhibition of nuclear factor kappa B activation by conditional ablation of IkB kinase 2 resulted in
strong preservation of central nervous system myelin, reduced expression of proinflammatory mediators and a significantly
attenuated glial response. Importantly, IkB kinase 2 depletion in astrocytes, but not in oligodendrocytes, was sufficient to protect
mice from myelin loss. Our results reveal a crucial role of glial cell-specific IkB kinase 2/nuclear factor kappa B signalling for
oligodendrocyte damage during toxic demyelination. Thus, therapies targeting IkB kinase 2 function in non-neuronal cells may
represent a promising strategy for the treatment of distinct demyelinating central nervous system diseases.
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Introduction
The rapid conduction of action potentials in the mammalian ner-
vous system depends on myelin, which forms an insulating
multi-lamellar structure around axons. This specialized organelle
is produced by Schwann cells in the PNS and by oligodendrocytes
in the CNS. The unique association between axons and glia is also
a key regulator of nerve regeneration after injury, promoting
axonal regrowth in the periphery while preventing it in the CNS.
During development of the CNS, oligodendroglial cells ensheath
axonal processes, assemble compact myelin and form the white
matter. Brain myelin formation during development is initiated by,
as yet, poorly identified signals from axons to oligodendrocytes.
There are interactions between axonal ligands and glial receptors,
e.g. neuregulins and ErbB receptor tyrosine kinases, which inte-
grate cell surface signals and modulate myelin thickness (Falls
2003; Michailov et al., 2004; Brinkmann et al., 2008).
Among the signalling pathways that orchestrate axonal en-
sheathment in the PNS via Schwann cell differentiation to a mye-
linating phenotype, nuclear factor kappa B (NF-kB) was shown to
be crucial for insulating axons (Nickols et al., 2003). NF-kB was
defined as one essential differentiation signal in the PNS; it was
highly upregulated in premyelinating Schwann cells and its block-
age markedly attenuated myelination (Nickols et al., 2003). Oct-6
and Krox-20, two additional transcription factors, known to be
induced after axonal contact and essential for the proper temporal
expression of myelin-specific genes in Schwann cells, are both
regulated via NF-kB (Topilko et al., 1994; Jaegle et al., 1996;
Nickols et al., 2003).
It is largely unknown whether NF-kB exerts similar functions in
oligodendrocytes of the CNS. NF-kB could also modulate the
remyelination process by oligodendrocytes, especially since
tumour necrosis factor (TNF), a prototypical inducer of NF-kB,
was shown to be required for both remyelination and proliferation
of oligodendrocyte progenitor cells (Arnett et al., 2001). Activation
of the canonical NF-kB pathway is induced by the IkB kinase (IKK)
complex, composed of two catalytic subunits, IKK1/a and IKK2/b,
and a regulatory subunit, NF-kB essential modulator (NEMO)/IKKg
(Hayden and Ghosh 2008). An alternative NF-kB activation
pathway has been described that involves NF-kB-inducing kinase
and IKK1 and mediates processing of the p100 precursor protein
resulting in the release of p52-containing dimers.
The present study addressed the role of NF-kB signalling in
oligodendrocyte differentiation and in the complex process of
CNS myelination throughout development and during de- and
remyelination using the demyelinating toxin cuprizone
(bis-cyclohexanone oxaldihydrazone). By applying CNS cell-
restricted inhibition of IKK2-mediated activation of the canonical
NF-kB pathway, we show that IKK/NF-kB signalling in glial cells is
critical for driving oligodendrocyte destruction and demyelination
in vivo. In contrast, IKK2 is dispensable for insulating axons during
development and remyelination. These data reveal a new function
for IKK2-mediated NF-kB activity during toxic demyelination. The
demonstration that NF-kB inhibition is protective during
non-inflammatory demyelination suggests that pharmacological
targeting of the IKK/NF-kB pathway, specifically in glial cells,
might have therapeutic effects in other demyelinating pathologies
such as multiple sclerosis.
Materials and methods
Mice
For IKK2 inactivation in all cells of the CNS or in oligodendrocytes
only, mice carrying loxP-IKK2 alleles (Pasparakis et al., 2002) were
crossed with transgenic mice expressing Cre recombinase under the
control of the nestin (Tronche et al., 1999) or the MOG promoter
(Hovelmeyer et al., 2005). Glial fibrillary acidic protein (GFAP)-
IkBa-dn animals were described previously (Brambilla et al., 2005).
All mice used in this study were backcrossed to the C57Bl/6 genetic
background for at least seven generations. Mice were bred in-house
under pathogen-free conditions.
Cuprizone and lysocithin treatment
Cuprizone experiments were performed on 6–8-week-old female mice.
The animals were housed under standard laboratory conditions with
food and water ad libitum. Mice were fed for 5 or 10 weeks with
0.2% (wt/wt) cuprizone (Sigma, St Louis, MO, USA) in the ground
breeder chow. The control group received breeder chow without
cuprizone admixture. We conducted two experimental series: in the
first experimental setup, analysis of light and ultrastructural level and
cytokine production was performed after 5 weeks of cuprizone treat-
ment; in the second setup, the cuprizone diet was discontinued after
5 weeks and animals were maintained for a further 5 weeks under
normal diet to allow spontaneous remyelination. For the remyelination
experiments, lysolecithin was stereotactically injected into the spinal
cord of 10–12-week-old mice, as described previously (Ousman and
David, 2000). Mice were anaesthetized with ketamine:xylazine
(100 mg/kg:20 mg/kg) and a dorsal laminectomy was performed at
spinal cord segment Th10. One microlitre of lysolecithin (Sigma), at
a concentration of 2 mg/ml, was injected into the ventral part of the
spinal cord, lateral to the central artery. Animals were sacrificed after
either four or 14 days and perfused with 2% paraformaldehyde/3%
glutaraldehyde for electron microscopy.
Histology and electron microscopy
Histology was performed as described recently (Prinz et al., 2006,
2008). Brains were removed and fixed in 4% buffered formalin.
Tissue was paraffin embedded before staining with haematoxylin
and eosin, luxol fast blue to assess the degree of demyelination,
MAC-3 (BD Pharmingen) for microglia, GFAP for astrocytes (Dako,
Hamburg, Germany), degraded myelin basic protein (Chemicon,
Billerica, USA) for myelin destruction, amyloid precursor protein for
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axonal damage (Chemicon), Nogo-A (mAb11c7; Oertle et al., 2003;
kindly provided by M. Schwab, University of Zurich), proteolipid pro-
tein, 20, 30-cyclic nucleotide 30-phosphodiesterase (CNP), and myelin
basic protein (Biozol, Eching) for mature oligodendrocytes and Olig 2
for oligodendrocyte precursors (Immuno-Biological Laboratories, USA).
Serial coronal sections were examined between levels 0.7 and
1.7 mm bregma according to the mouse brain atlas of Franklin
and Paxinos (1997). Demyelination was scored as described, ranging
from 0 (no demyelination) to 3 (complete demyelination) (Hiremath
et al., 1998). The total number of MAC-3 + microglia and GFAP +
astrocytes in the lateral and medial part of the corpus callosum was
counted using 400 magnification and cellularity was calculated as
cells per mm2. For assessment of oligodendrocyte precursors, rabbit
anti-NG2 antibody (Chemicon) was used 1:200 on floating cryosec-
tions. For immunohistochemical detection of nuclear translocated p65,
sections were stained with antibodies to NF-kB p65 (Santa Cruz).
Terminal deoxynucleotidyl transferase dUTP nick end labelling staining
was performed according to the manufacturer’s protocol (TUNEL,
Oncor).
For electron microscopy, sections from Epon-embedded,
glutaraldehyde-fixed corpus callosum were cut and stained with tolui-
dine blue. The tissue was then trimmed and reoriented so that
ultrathin cross sections of the midline corpus callosum could be cut
and treated with uranyl acetate and lead citrate. Electron micrographs
were analysed for fibre diameter, axon diameter and myelin thickness
using the analySIS Docu System (Soft Imaging System GmbH,
Germany). G ratios were defined as diameter of the axon divided by
fibre diameter (axon plus myelin). We calculated a G ratio for each
fibre and subsequently averaged all G ratios from one brain. In add-
ition, the number of myelinated fibres in relation to all fibres was
expressed as percentage of axons with a diameter of 4250 nm to
all visible axons.
Cell cultures
Primary astrocytes and microglia were prepared from newborn mice as
described previously (Prinz and Hanisch, 1999; Mildner et al., 2007).
Purified astrocytes and microglia were seeded at a density of 2  105
cells/6 wells and murine recombinant TNFa (10 ng/ml), IL-1b (10 ng/
ml) or IFNg (10 ng/ml) was added to the cell culture medium for
30 min to 1 h. For cell stimulation, cuprizone was added to primary
glial cells at 25mM for 90 min. For p65/RelA nuclear translocation cells
were analysed by immunofluorescence using antibodies against GFAP
(Chemicon) and p65/RelA (Santa Cruz). Five random optical fields
were taken, with 100 cells counted per optical field; the results are
presented as mean  SEM. Oligodendrocyte enriched glial cell cultures
were prepared according to a modified protocol for rats as described
earlier (Prinz et al., 2004).
Western blot
Immunoblots were performed as described previously (van Loo et al.,
2006). In brief, total cell or brain extracts were separated by sodium
dodecyl sulphate polyacrylamide gel electrophoresis (10%) and trans-
ferred to polyvinylidene fluoride membranes (Bio-Rad, Mu¨nchen,
Germany). Membranes were probed with mouse anti-IKK2
(Imgenex, San Diego, USA) and mouse anti-actin (Chemicon) antibo-
dies and detected by chemiluminescent peroxidase substrate (Sigma,
Steinheim, Germany). For detection of myelin proteins, brains were
homogenized in Laemmli buffer and protein lysates were separated
by sodium dodecyl sulphate polyacrylamide gel electrophoresis. Upon
blotting, nitrocellulose membranes were probed with antibodies recog-
nizing CNPase (Sigma 11-5B) and myelin basic protein (Millipore
AB980) as well as anti b-actin to monitor loading.
Laser microdissection
Microdissection of 150 astrocytes and microglia per mouse was
performed using a Leica AS LMD system (DM 6000B, Leica
Microsystems) as described before, with modifications (Burbach
et al., 2004). Fast immunochemistry of serial brain sections from
cuprizone-treated and untreated mice was performed for astrocytes
with GFAP (DAKO, Hamburg, Germany) and for microglia with
CD11b antibodies (BMA Biomedicals, Augst, Switzerland).
Immunostained sections were counterstained with Hoechst 33342
(Sigma-Aldrich) to facilitate the identification of individual cells. RNA
was isolated with the RNeasy Micro Plus Kit (Qiagen, Hilden,
Germany) and reverse transcription, pre-amplification and real-time
polymerase chain reaction were performed using Applied Biosystems
(Darmstadt, Germany) reagents according to the manufacturer’s
recommendations.
Real-time polymerase chain reaction
RNA was extracted from diseased mice challenged with cuprizone. The
tissue was flushed with ice cold Hank’s buffered salt solution and RNA
was isolated using RNeasy Mini kits (Qiagen), following the
manufacturer’s instructions, and the polymerase chain reaction was
performed as described recently (Prinz et al., 2006). The following
primer probe pairs were used: CCL2 (sense TCTGGGCCTGCT
GTTCACC, antisense TTGGGATCATCTTGCTGGTG), CXCL10 (sense
TGCTGGGTCTGAGTGGGACT, antisense CCCTATGGCCCTCATT
CTCAC), CCL3 (sense CACCACTGCCCTTGCTGTT, antisense AG
GAGAAGCAGCAGGCAGTC), TNFa (sense CATCTTCTCAAAATTCGA
GTGACAA, antisense TGGGAGTAGACAAGGTACAACCC), IL-1b
(sense ACAAGAGCTTCAGGCAGGCAGTA, antisense ATATGGG
TCCGACAGCACGAG), CNP (sense TGGTGTCCGCTGATGCTTAC,
antisense CCGCTCGTGGTTGGTATCAT), myelin-associated glycopro-
tein (sense GGTGTTGAGGGAGGCAGTTG, antisense CGTTCTCTG
CTAGGCAAGCA), Olig1 (sense CGACGCCAAAGAGGAACAG, anti-
sense GCCAAGTTCAGGTCCTGCAT) and SOX2 (sense AACTTTTGT
CCGAGACCGAGAA, antisense CCTCCGGGAAGCGTGTACT).
Statistical analysis
Statistical differences of clinical scores were evaluated using a
non-paired Student’s t-test. Differences were considered significant
when P5 0.05.
Results
Formation of myelin in the central
nervous system in the absence of
the canonical nuclear factor kappa
B pathway activator IkB kinase 2
As NF-kB activation has been shown to be an essential signal for
the progression of axon-associated Schwann cells into a
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myelinating phenotype in the PNS (Nickols et al., 2003), we
hypothesized that NF-kB might also be required for the formation
of myelin in the brain. We therefore generated mice with
CNS-restricted knockout of IKK2 (IKK2CNS-KO) by crossing mice
carrying loxP-flanked IKK2 alleles (Pasparakis et al., 2002) with
Nestin-Cre transgenic mice (Tronche et al., 1999). Immunoblot
analysis of brain region extracts as well as cell lysates from neu-
roectodermal astrocytes confirmed the efficient ablation of IKK2 in
IKK2CNS-KO mice (Fig. 1A). Mesodermal-derived microglia were
not affected.
We next performed a detailed histological examination of the
CNS of adult IKK2CNS-KO mice for any signs of dys- or demyelin-
ation. Adult IKK2CNS-KO brains showed normal myelin distribution
and no signs of altered myelination at the light microscopy level
(Fig. 1B). Frontal sections of the brain revealed normal myelin fibre
tracts on proteolipid protein immunohistochemistry (Fig. 1B, left)
in the corpus callosum. Accordingly, immunohistochemistry for the
astrocyte-specific marker GFAP did not show any gliotic changes
and exhibited morphologically unaltered astrocytes in
IKK2-deficient brains (Fig. 1B, right). Further electron microscopy
examinations showed comparable numbers of myelinated axons
with structurally intact myelin sheath and regular thickness be-
tween IKK2CNS-KO and IKK2CNS-wild-type mice (Fig. 1C). In order
to examine whether myelin composition is normal in the absence
of NF-kB signalling, we performed quantitative real-time polymer-
ase chain reaction and immunoblot analysis of the expression of
myelin proteins CNP, myelin-associated glycoprotein, oligodendro-
cyte transcription factor 1 (Olig1), myelin basic protein and the
neural stem cell marker SOX2 from brain lysate (Supplementary
Fig. 1A and B). Expression of all myelin proteins tested was similar
in mutant animals and wild-type controls. Quantification of
Olig2 + oligodendroglial progenitor cells and mature oligodendro-
cytes revealed normal numbers in both corpus callosum and cortex
in the absence of IKK2 (Fig. 1D). Furthermore, normal numbers of
oligodendrocyte precursor cells (NG2 + ) were obtained from new-
born IKK2CNS-KO mice, with no obvious differentiation defects or
morphological abnormalities in primary cultures (Fig. 1E). Cells
from both wild-type and mutant mice expressed CNP and
myelin basic protein at a mature developmental stage and dis-
played similar numbers of well-developed large processes,
extensive lacy arborisations and membrane sheets. In summary,
these data show that IKK2-mediated NF-kB activation is dispens-
able for oligodendrocyte maturation in vitro and in vivo, and sub-
sequent insulation of axons in the CNS. These results are in sharp
contrast to the previously reported crucial role of NF-kB signalling
for myelination in the PNS (Nickols et al., 2003), suggesting that
NF-kB has different functions in peripheral and central nervous
system myelination. We therefore examined NF-kB activation
during myelination in the CNS in the white and grey matter and
in the PNS by immunostaining for the p65/RelA NF-kB subunit
during the second post-natal week (Supplementary Fig. 2).
Consistent with the observed phenotypes, robust nuclear p65
signal, indicating NF-kB activation, could be found in the
Schwann cells of the peripheral nerves, whereas white matter
oligodendrocytes and cortical neurons did not show nuclear p65
at the same age.
Pivotal role of the classical NF-kB
pathway for toxic demyelination
To assess the role of CNS-specific IKK2-mediated NF-kB activation
for CNS myelin damage in vivo, IKK2CNS-KO mice were tested in
the cuprizone model, a model of toxic demyelination (Mildner
et al., 2007). Treatment with cuprizone leads to substantial de-
myelination in the corpus callosum after 4–5 weeks of administra-
tion. Spontaneous remyelination can be observed as early as four
days after withdrawal of the agent, making cuprizone an excellent
tool to study the mechanisms involved in de- and remyelination
(Matsushima and Morell, 2001). Furthermore, cuprizone-induced
demyelination shows similarities to lesions seen in experimental
autoimmune encephalomyelitis and multiple sclerosis (Gold
et al., 2006). We first determined in wild-type mice in which
cells NF-kB is activated during toxic demyelination (Fig. 2A). We
readily detected nuclear translocation of p65/RelA, the main trans-
activating NF-kB subunit, in the demyelinating corpus callosum
after 5 weeks of cuprizone exposure. Increased nuclear p65 immu-
noreactivity was mainly visible in GFAP + astrocytes (192.0 
44.3 cells/mm2) and MAC-3 + microglia (814.9  142.9 cells/
mm2) and only occasionally in Nogo-A + oligodendrocytes at the
lesion border.
To investigate the possible effects of NF-kB inhibition for oligo-
dendrocyte damage, we examined histologically the corpus callo-
sum of IKK2CNS-KO mice fed with cuprizone for 5 weeks (Fig. 2B).
In control mice, luxol fast blue staining revealed extensive loss of
myelin accompanied by the accumulation of numerous activated
MAC-3 + microglia and strong astrogliosis (GFAP). In contrast, loss
of myelin and gliosis were strongly reduced in the brain of
IKK2CNS-KO mice. Accordingly, the number of NG2 + oligodendro-
cyte precursor cells in the corpus callosum tended to be lower in
protected IKK2CNS-KO mice (Fig. 2C). We then determined the
expression of the NF-kB-dependent cytokines and chemokines
IL-1b, TNFa, CCL2, CCL3 and CXCL10 that potentially contribute
to oligodendrocyte toxicity in this model (Fig. 2D). In IKK2CNS-KO
mice, the induction of IL-1b and TNFa was significantly diminished
(P5 0.05). Furthermore, the expression of CCL2, CCL3 and
CXCL10 was reduced in IKK2CNS-KO mice compared with
wild-type controls.
To estimate the degree of demyelination on ultrastructural level,
we counted the number of myelinated axons in Epon-embedded
corpora callosa (Fig. 2E). In wild-type mice, only 20  12% of all
axons remained myelinated after cuprizone treatment. In contrast,
63  7% (P50.05) of all axons were enwrapped with myelin
sheaths in IKK2CNS-KO mice.
In order to examine demyelination kinetics in brain-specific
IKK2CNS-KO animals, we investigated the degree of demyelination
at further time points during prolonged exposure to cuprizone for
up to 10 weeks (Fig. 3). The number of Nogo-A + oligodendro-
cytes was dramatically reduced in wild-type animals already at
3 weeks (124.7  7.8 cells/mm2 in treated versus 412.1 
23.4 cells/mm2 in untreated mice) and further declined until
5 weeks (28.9  2.1 cells/mm2; Fig. 3A). In sharp contrast,
IKK2CNS-KO animals exhibited only a subtle oligodendrocyte
loss after 3 weeks (378.4  14.5 cells/mm2 in treated versus
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Figure 1 The canonical NF-kB pathway activator IKK2 is dispensable for formation of myelin in the CNS. (A) Immunoblot analysis of
lysates demonstrating brain and neuroectoderm-specific deletion of IKK2. Data are representative of four independent experiments.
Lysates from total brain, cortex and subcortex were generated from mice at the age of 6–8 weeks. Lysates from astrocytes and microglia
derived from newborn mice primary cell cultures. (B) Proteolipid protein expression reveals proper myelination and the absence of any
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(continued)
414.7  18.8 cells/mm2 in untreated mice) that reached its max-
imum at 5 weeks (237.2  16.5 cells/mm2) and remained stable
during the chronic disease phase. Accordingly, demyelination mea-
sured by luxol fast blue staining was less prominent in
brain-specific IKK2-deficient animals (Fig. 3A and C). The increase
in demyelination was paralleled by a decrease in myelin proteins
evident at 3 weeks (Fig. 3B). Consistent with the histologically
evident protection from demyelination, IKK2CNS-KO animals
showed only mildly decreased myelin protein gene expression.
Interestingly, the expression of CNP, Olig1 and myelin-associated
glycoprotein spontaneously increased until 5 and 10 weeks. This
transcriptional response associated with repair was further charac-
terized by the subsequent increase of the neuronal stem cell factor
SOX2. Despite significant myelin preservation in brains lacking
NF-kB signalling, the glial response was vigorous after 10 weeks
of cuprizone with abundant microglia and astrocytes that were
found in similar numbers in the mutant mice (1168.0  89.9
MAC-3 + cells/mm2 compared with 1174.1  321.5 cells/mm2 in
wild-type mice and 408.5  22.1 GFAP + cells/mm2 versus
373.7  44.3 cells/mm2 in wild-type, Fig. 3C). Taken together,
these findings show that inhibition of IKK2 mediated NF-kB sig-
nalling by deletion of IKK2 in all CNS-resident neuroectodermal
cells is associated with decreased expression of key proinflamma-
tory mediators involved in toxic damage of oligodendrocytes,
resulting in protection from myelin loss.
Oligodendrocyte-restricted IkB kinase
2 is dispensable for demyelination and
remyelination in vivo
As the Nestin-Cre transgene is highly expressed in all neuroecto-
dermal cells, which results in efficient gene inactivation in neurons,
astrocytes and oligodendrocytes, we wondered whether the resist-
ance of IKK2CNS-KO mice to demyelination is due to a cell autono-
mous protective function of IKK2 inhibition in oligodendrocytes.
Cell specificity of Cre recombination in MOGi-Cre transgenic mice
has been demonstrated (Hovelmeyer et al., 2005). We therefore
generated mice lacking IKK2 only in oligodendrocytes
(IKK2Oligo-KO) by crossing Ikk2FL mice with MOGi-Cre knock-in
mice, which express Cre specifically in mature oligodendrocytes.
Mice with oligodendrocyte-restricted ablation of IKK2 developed
normally without any clinical signs of disease. Upon histological
examination the number of mature Nogo-A + oligodendrocytes
was found to be normal in all brain regions tested
(Supplementary Fig. 3A). Furthermore, CNS myelination was un-
changed and oligodendrocyte morphology and differentiation
in vitro were normal (Supplementary Fig. 3B).
However, upon toxin-induced (cuprizone, Fig. 4) or autoimmune-
mediated (MOG35-55 specific T cells in experimental autoimmune
encephalomyelitis; data not shown) demyelination, IKK2Oligo-KO
mice showed extensive myelin loss and pronounced gliosis similar
to wild-type mice. Accordingly, equal numbers of NG2+ oligo-
dendrocyte precursor cells were found in the corpus callosum of
mutant and control mice after 5 weeks of cuprizone treatment
(Fig. 4C). Disease incidence, onset and clinical course of EAE
were identical in IKK2Oligo-KO and IKK2Oligo-wild-type mice (data
not shown). Thus, oligodendrocyte-restricted IKK2-deficiency
does not affect oligodendrocyte damage in either chemically
induced or autoimmune demyelination.
IkB kinase 2 is not required for
remyelination in the central
nervous system
Remyelination is a complex repair process ensuring cellular integ-
rity after neuronal damage, as well as after primary loss of mature
oligodendrocytes. The cuprizone model is a suitable tool to study
both the kinetics and the underlying molecular mechanisms of
remyelination in vivo. Since IKK2Oligo-KO mice showed similar
cuprizone-induced demyelination compared with control animals,
we used them to examine the role of IKK2-mediated NF-kB acti-
vation in oligodendrocytes during remyelination. IKK2Oligo-KO mice
were treated with cuprizone for 5 weeks followed by 5 weeks
feeding with normal chow without cuprizone to allow the gener-
ation of new oligodendrocytes. Semiquantitative assessment of
luxol fast blue stainings and ultrastructural morphometric analysis
(data not shown) revealed no obvious differences between both
genotypes. Thus, IKK2/NF-kB signalling in oligodendrocytes in the
cuprizone demyelination model is not essential for remyelination in
the adult CNS.
Figure 1 Continued
gross abnormalities within the CNS in the absence of IKK2 (left panel) at the age of 6–8 weeks. GFAP-expressing astrocytes are normally
distributed within the white matter tract of the corpus callosum (right). Analysis was performed with mice at the age of 6–8 weeks. Scale
bars = 500mm (left panel) and 50 mm (right panel). (C) Ultrastructural micrographs showing myelination in the corpus callosum at dif-
ferent time points of myelination. Scale bar = 400 nm (left). Measurements of axon diameter, myelin thickness, G ratio and percentage of
myelin fibres in the corpus callosum of three and 25-week old IKK2CNS-KO (filled squares) or wild-type (WT) mice (open squares, right).
There are no differences between the mean group values for any parameter in either genotype or at either developmental stage. Each
point represents the mean value from at least 100 individual axonal measurements. (D) The number of oligodendroglial progenitor cells
and mature oligodendrocytes was quantitatively examined on histological sections of corpus callosum and cortex in 2–3-week old
IKK2CNS-KO and IKK2CNS-wild-type mice. Olig2 immunohistochemistry (left) and quantification thereof (right). Data are expressed as
mean  SEM of at least three mice per group. (E) Unaltered oligodendrocyte differentiation and morphology in IKK2CNS-KO mice. Primary
oligodendrocytes were cultured and kept for different maturation stages. Double immunofluorescence with DAPI for nuclear staining
(blue) and NG2 (red), myelin basic protein (red) or CNP (green), respectively (left panel). Scale bar = 10 mm. Quantification of differentially
expressed maturation marker for oligodendrocytes after three days in culture (right). Data indicate the mean of cells expressing the
differentiation marker. Data are representative of two independent experiments. MBP = myelin basic protein.
IKK2 and CNS myelination Brain 2011: 134; 1184–1198 | 1189
Figure 2 Inhibition of NF-kB signalling in the brain ameliorates demyelination and reduces induction of toxic cytokines in the CNS.
(A) NF-kB p65 translocation is induced in neuroectodermal and myeloid cells of the brain during acute demyelination.
Immunofluorescence of p65 depicts strong nuclear signal in numerous GFAP + astrocytes (arrow, left panel), Nogo-A + oligodendrocytes
(arrows, middle panel) and MAC-3 + microglia (arrows, right panel). Inserts illustrate the absence of nuclear p65 translocation in
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(continued)
We therefore wanted to address the role of IKK2 in other cells
of the CNS during remyelination using the IKK2CNS-KO animals.
Since IKK2CNS-KO mice were protected from cuprizone-induced
demyelination, we explored alternative models and chose lysole-
cithin as a potential alternative to induce demyelination in the CNS
(Arnett et al., 2004). First, lysolecithin was stereotactically injected
into the spinal cord of wild-type mice and subsequent demyelin-
ation was assessed. Comparative histopathological analysis of
cuprizone- and lysolecithin-induced changes in the CNS revealed
striking differences in the lesion pattern as well as in the inflam-
matory make up of the infiltrates (Fig. 5). Lysolecithin evoked at
peak of destruction fulminant axonal damage as revealed by amyl-
oid precursor protein accumulation in axonal spheroids accompa-
nied by strong accumulation of infiltrating macrophages/microglia
(MAC-3), whereas the astrocytic response was only scarce. In
contrast, at a comparable disease stage, cuprizone provoked a
strong astrogliosis and no obvious axonal damage.
Interestingly, in contrast to our findings in the cuprizone model,
lysolecithin-induced demyelination was found to be almost com-
plete even in IKK2-deficient brains similarly to wild-type mice
(Fig. 6A). The complete demyelination in the lysolecithin model
in contrast to cuprizone exposure might be due to differences in
the underlying pathophysiology and their diverse consequences on
the CNS in terms of subsequent damage and demyelination.
IKK2CNS-KO and control mice were injected with lysolecithin and
were analysed 14 days later for remyelination. Ultrastructural mor-
phometric analysis of remyelinated spinal cords at Day 14 after
lysolecithin injection revealed no significant differences in the G
ratios (G ratio 0.93  0.01 for both genotypes), axon diameter,
myelin thickness or the percentage of myelinated axons between
IKK2CNS-KO and control mice (48.0  5.6% for IKK2CNS-KO and
41.0  3.3 for wild-type P40.05) (Fig. 6B). Taken together,
these data demonstrate that the process of myelin repair in the
lysolecithin model of demyelination is independent of CNS
cell-specific IKK2 expression.
Inhibition of neuroectodermal nuclear
factor kappa B activation by IkB kinase
2 results in reduced myelin loss
The experiments in IKK2Oligo-KO mice showed that the protection
of IKK2CNS-KO mice from cuprizone-induced demyelination is not
caused by oligodendrocyte-intrinsic IKK2-deficiency.
Astrocytes are one of the major cell types responding to acute
as well as chronic damage of the CNS. Following a lesion, they
rapidly proliferate and secrete a variety of immunological factors
such as proinflammatory cytokines, as well as extracellular matrix
molecules (Dong and Benveniste, 2001). Upregulation of GFAP is
one hallmark of astrocytic response in the damaged brain.
To determine whether astrocytes are cellular sources of potential
detrimental cytokines during demyelination, messenger RNA levels
for different NF-kB-dependent cytokines and chemokines were
measured in conditions of acute demyelination. For microdissec-
tion of astrocytes and microglia, GFAP and CD11b immunohisto-
chemistry on brain sections containing the corpus callosum was
performed (Fig. 7A). Immunostained sections were counterstained
with Hoechst 33342 to facilitate the identification of individual
cells. These immunostained serial sections were then used to dis-
sect GFAP+ astrocytes (upper row) and CD11b + microglia (lower
row) from the lesion site by a pulsed UV laser beam. Cytokine
messenger RNA expression was subsequently analysed by quanti-
tative real-time polymerase chain reaction (Fig. 7B). We found a
9.1  2.4-fold increase of CXCL10 messenger RNA in astrocytes
from wild-type mice subjected to cuprizone compared with cells
from untreated mice. Inhibition of neuroectodermal NF-kB re-
sulted in strongly reduced expression of CXCL10 in IKK2CNS-KO
mice (3.6  0.1-fold) whereas microglial CXCL10 levels were
only slightly reduced (8.4  2.9-fold in IKK2CNS-wild-type and
6.6  1.8-fold in IKK2CNS-KO). Similarly, CCL2 transcripts were
upregulated in wild-type astrocytes in diseased brains
(6.1  2.7-fold) and robustly decreased in IKK2 lacking astrocytes
(0.7  0.5-fold) whereas microglial CCL2 was not influenced by
the absence of the NF-kB activator IKK2 in neuroectodermal cells
(1.3  0.4-fold in IKK2CNS-wild-type and 0.9  0.5-fold in
IKK2CNS-KO). Expression of CCL3 was only slightly modulated in
astrocytes and microglia IKK2CNS-KO mice. Inactivation of
IKK2-mediated NF-kB activation in IKK2CNS-KO mice decreased
TNFa transcripts from 6.5  3.0-fold in wild-type astrocytes to
1.2  0.4-fold. Notably, TNFa expression in microglia was not
influenced in IKK2CNS-wild-type and IKK2CNS-KO cuprizone-treated
mice (26.1  8.6-fold compared with 27.3  4.3-fold).
Furthermore, we addressed the contribution of astroglial NF-kB
myelin loss in vivo by using a transgenic mouse strain in which
NF-kB was selectively inhibited in astrocytes by overexpression of
a dominant negative form of the NF-kB inhibitor IkBa (IkBa-dn)
under the control of the astrocyte-specific GFAP promoter
(Brambilla et al., 2005). Histological analysis of the corpus
Figure 2 Continued
neuroectodermal glia cells of IKK2CNS-KO mice. Scale bar = 25mm. (B) Histopathological analysis of the corpus callosum from
IKK2CNS-wild-type and IKK2CNS-KO mice 5 weeks after cuprizone treatment. Sections were examined for demyelination by luxol fast blue
(LFB), for microglia by MAC-3 and for astrogliosis by GFAP immunohistochemistry. Representative sections are shown left and
quantification thereof is depicted on the right. (C) The presence of NG2 + cells in the corpus callosum of mice treated with cuprizone is
shown by immunofluorescence (red). Nuclei are stained in blue (DAPI). Inserts depict higher magnification. Scale bars = 30 mm and 7mm
(inserts). The number of NG2 + cells per mm2 is shown on the right (mean  SEM). (D) Quantification of cytokine and chemokine
messenger RNA expression in the corpus callosum of IKK2CNS-wild-type and IKK2CNS-KO mice 5 weeks after cuprizone treatment. (E) Electron
micrographs depicting highly preserved myelin sheaths in mice lacking IKK2 in all neuroectodermal cells of the brain. The number of
myelinated axons is greatly reduced in the presence of canonical NF-kB signalling as quantified in at least 100 axons of a diameter
5250 nm after acute corpus callosum demyelination. Scale bar = 400 nm. *P50.05; **P5 0.01, ***P50.001.
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callosum after 5 weeks of cuprizone-mediated demyelination
showed clearly more preserved myelin in GFAP-IkBa-dn mice
compared with control wild-type littermate mice (Fig. 7C). In add-
ition, reduced GFAP and MAC-3 immunoreactivity was detected
in mutant animals indicating a diminished gliosis. To investigate
the molecular mechanisms behind the improved myelin preserva-
tion in GFAP-IkBa-dn mice, we evaluated the expression of
NF-kB-dependent genes in the corpus callosum (Fig. 7D).
Figure 3 Gene expression pattern is temporally altered during chronic demyelination in the absence of IKK2. (A) Time course of de-
myelination (upper panel) and the number Nogo-A + oligodendrocytes (lower panel) in IKK2CNS-wild-type (open squares) and IKK2CNS-KO
(filled squares) mice. Data show mean  SEM from at least three mice per group. (B) Levels of myelin transcripts in the corpus callosum of
IKK2CNS-wild-type (open squares) and IKK2CNS-KO (filled squares) mice treated with cuprizone over time, measured by quantitative real-time
polymerase chain reaction, normalized to GAPDH and expressed in relation to untreated mice (n5 3). Mean  SEM from at least three
mice per group is depicted. (C) Attenuated demyelination is found in the corpus callosum of chronically treated animals after 10 weeks in
the absence of canonical NF-kB activation. Representative histological sections are shown left and the quantification is given right. Data
show mean  SEM from one representative experiment out of two with at least five mice per group. *P50.05. Scale bar = 300 mm.
LFB = luxol fast blue; MAG (myelin associated glycoprotein) = MAC-3 for microglia and GFAP for astrocytes.
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Corpus callosum messenger RNA levels for multiple cytokines and
chemokines were statistically significant different between
wild-type and transgenic animals showing a clear reduction in
TNFa, IL-1b and CCL2 in GFAP-IkBa-dn. On the contrary, levels
of CCL3 and CXCL10 were not statistically different. These results
show that inhibiting NF-kB in astrocytes effectively reduces the
inflammatory response that is associated with myelin damage in
the cuprizone model.
To further investigate the mechanisms that underlie myelin pro-
tection in IKK2CNS-KO mice on the cellular level, we prepared
astrocytes and microglia from IKK2CNS-KO and wild-type mice.
We measured NF-kB nuclear localization in cultured astrocytes
upon stimulation with lipopolysaccharide. Astrocytes from wild-
type mice had a robust NF-kB activation, as demonstrated by
nuclear translocation of p65 (Supplementary Fig. 4A). In contrast,
mutant astrocytes displayed impaired p65 nuclear translocation,
showing that IKK2 deficiency inhibits NF-kB activation in
IKK2CNS-KO astrocytes. We then tested the capacity of
IKK2-deficient astrocytes to express NF-kB target genes upon
stimulation. IKK2-ablated astrocytes failed to mount a strong ex-
pression of IL-1b, CCL2 or CXCL10 messenger RNAs, demonstrat-
ing that IKK2-dependent NF-kB activation is crucial for efficient
induction of proinflammatory mediators by astrocytes. In contrast
to astrocytes, microglia derive from the mesoderm (Priller et al.,
2001; Mildner et al., 2007) and should therefore not be targeted
by the Nestin-Cre transgene. Indeed, microglia from wild-type and
mutant mice showed similar NF-kB activation and induction of
proinflammatory genes in response to lipopolysaccharide, demon-
strating that microglia in IKK2CNS-KO mice do not have impaired
NF-kB signalling (Supplementary Fig. 4B). Cuprizone, however,
could not induce nuclear p65 translocation in astrocytes in vitro,
not alone or in combination with lipopolysaccharide or TNFa, nor
could it induce the induction of TNFa, IL-1b, IP-10 messenger
RNAs after stimulation (data not shown). Indicating that,
Figure 4 NF-kB signalling in mature oligodendrocytes is not pathogenic during demyelination. (A) Analysis of paraffin sections indicate
the same pattern (left) and extend (right) of demyelination (luxol fast blue, LFB), infiltrating microglia (MAC-3) as well as astrogliosis
(GFAP) after cuprizone treatment for 5 weeks. Data show mean  SEM from one representative experiment out of three. Scale
bar = 300 mm. (B) Similar number of NG2 + progenitor cells in IKK2Oligo-wild-type and IKK2Oligo-KO mice 5 weeks after cuprizone treatment.
Representative mean  SEM of two similar experiments is shown. Scale bar = 20 mm.
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cuprizone does not seem to induce an inflammatory response
leading to demyelination by directly acting on astrocytes. It
seems more likely that astrocyte activation is an indirect effect
of an initial insult induced in oligodendrocytes by the cuprizone
treatment. With ongoing degradation of oligodendrocytes and
their ensheathing membranes, glial cells are recruited to the site
of damage where they are activated and release a plethora of
potentially harmful factors contributing to and amplifying tissue
damage in vivo.
Discussion
Here we investigated the role of NF-kB activator in mediating
oligodendrocyte maturation, myelination, de- and remyelination
in the CNS using different experimental paradigms. The NF-kB
pathway can be activated by diverse stimuli, including inflamma-
tory cytokines such as TNF, neurotrophic factors like nerve growth
factor, neurotransmitters, cell adhesion molecules and various
types of cell stress (Hayden and Ghosh, 2008). NF-kB was also
shown to play an important role in regulating cell survival and
synaptic plasticity in the CNS (Mattson and Camandola, 2001).
Only recently, activation of the classical NF-kB pathway has
been shown to be crucial in CNS-related pathologies such as in
ischaemic stroke and autoimmune inflammation (Herrmann et al.,
2005; van Loo et al., 2006; Brambilla et al., 2009). In general,
the reported roles of IKK2 vary considerably depending on
the context of investigation and the model systems that
were applied. The described functions of IKK2 range from the pro-
motion to the inhibition of cancer, tissue development, tissue regen-
eration, inflammation, as well as the induction or inhibition of
apoptosis (Gerondakis et al., 2006; Schmid and Birbach, 2008).
Although previous elegant studies have established the cellular
dynamics of myelination (Bunge et al., 1989), it remains a mystery
how signals are communicated to myelinating cells from axons
and adjacent myelinating cells. Some cues from axons stimulate
a genetic programme in Schwann cells and oligodendrocytes that
involves the production of specialized membranes with very high
content of cholesterol, sphingolipids and myelin-specific proteins
(Michailov et al., 2004; Kassmann et al., 2007).
Previously, Nickols and colleagues (2003) provided compelling
evidence that NF-kB orchestrates the process of myelination in
Schwann cells of the PNS. They found that NF-kB activity in the
sciatic nerve of developing rodents was at its maximum during the
period when Schwann cells were actively myelinating axons. Most
importantly, an essential role for NF-kB in Schwann cell differen-
tiation and myelination in vitro was established by blocking NF-kB
activity with a peptide inhibitor or by overexpression of a mutant
(dominant repressor) form of IkBa. Moreover, the production of
myelin was drastically reduced in dorsal root ganglion neurons
cultured from mice lacking the p65 subunit of NF-kB. We show
here that in contrast to the PNS, NF-kB activation by IKK2 in the
CNS is dispensable for the differentiation of oligodendrocytes and
the process of myelination during development. These results may
come as a surprise, since inflammatory cytokines, such as those
produced by glial cells during demyelination and remyelination, are
potent inducers of NF-kB in a variety of cell types, including
Figure 5 Diverse lesion pattern and different inflammatory
make up in two distinct demyelination models.
(A) Immunohistochemical examination of inflammation and
myelin and axonal damage during acute toxic demyelination in
the lysolecithin model at peak of disease (4 days after injection)
compared with the maximal response after cuprizone challenge
(5 weeks of treatment). MAC-3 staining revealed a plethora of
macrophages/microglia in both lesion models, whereas signifi-
cantly more GFAP + astrocytes were found in cuprizone-induced
lesions during acute myelin loss. Lymphocytes (CD3 for T cells,
B220 for B cells) were scarce in both models. Notably, amyloid
precursor protein (APP) deposits representing axonal damage
were clearly detectable only on the lysolecithin model.
(B) Histopathology of infiltration and axonal damage during
remyelination after lysolecithin (14 days after injection) and the
cuprizone (5 weeks treatment and 5 weeks recovery) model.
Data show mean  SEM from one representative experiment
out of two with at least four or five mice per group.
Scale bar = 400mm low magnification; scale bar = 40mm
high magnification. *P50.05, **P50.01, LFB-periodic
acid-Schiff = luxol fast blue-periodic acid Schiff.
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oligodendrocytes and Schwann cells (Arnett et al., 2001; Nicholas
et al., 2001; Huang et al., 2002; Hamanoue et al., 2004).
Nevertheless, we could not establish an essential role for the
IKK2-mediated activation of the NF-kB pathway during develop-
mental myelination and remyelination using cell-specific inhibition
of NF-kB signalling in neuroectodermal cells of the brain.
Consistent with these results, we found that NF-kB was activated
in Schwann cells in the PNS but not in oligodendrocytes in the
CNS during myelination, similar to previous reports (Bakalkin
et al., 1993; Schmidt-Ullrich et al., 1996; Nickols et al., 2003).
As the nestin promoter, driving Cre expression in IKK2CNS-KO mice
as used in our study, is already active during early embryogenesis,
oligodendrocytes having their maximal activity during post-natal
myelination should be targeted. We therefore conclude that in
contrast to Schwann cells in the PNS, oligodendrocytes do not
require IKK2 mediated NF-kB activation for orchestrating axon
myelination in the CNS. Furthermore, our data also argue against
a role for IKK2-mediated NF-kB activation in regulating the
remyelination process by oligodendrocytes. This is an important
issue as TNF was shown to be required for both remyelination
and proliferation of oligodendrocyte progenitor cells (Arnett
et al., 2001). NF-kB activation is further thought to be important
in response to stress and injury (Vollgraf et al., 1999). Other
in vitro studies have shown that NF-kB exhibits antagonistic prop-
erties in oligodendrocytes; it has a pro-survival role and promotes
maturation of oligodendrocyte progenitor cells (Nicholas et al.,
2004), a finding that was not apparent by our in vivo study as
we observed a similar amount of terminal deoxynucleotidyl trans-
ferase dUTP nick end labelling positive cells in the developing
IKK2-deficient brain (not shown) and a normal number of
mature oligodendrocytes in the adult corpus callosum.
Immunoreactivity for p65 NF-kB in oligodendrocytes located at
the edge of active lesions and in macrophages/microglia through-
out plaques has been reported in multiple sclerosis, suggesting
oligodendrocyte involvement in the repair process (Bonetti et al.,
1999). Despite the fact that our data do not indicate an active role
for oligodendrocyte-specific IKK2 during remyelination, we can
not exclude that the use of a different oligodendrocyte-specific
Figure 6 Remyelination in the CNS is independent from canonical NF-kB activation by IKK2. (A) Transmission electron microscopy
revealed a similar extent of demyelination induced by lysolecithin four days after treatment (left). Percentage of myelinated fibres is shown
for IKK2CNS-wild-type (open squares) and IKK2CNS-KO mice (filled squares). Each symbol represents the mean value from at least 20
individual measurements in each mouse. (B) Morphologically compatible structures of myelin in the remyelination phase 14 days after
lysolecithin exposure in both genotypes (left). Measurements of the percentages of myelinated axons, myelin thickness, G ratio and axon
diameter in the spinal cord of IKK2CNS-wild-type (open squares) and IKK2CNS-KO mice (filled squares). Scale bar = 400 nm. Each point
represents the mean value from at least 50 individual axonal measurements.
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promoter driving the Cre (such as CNP Cre) might depict a role for
NF-kB activation in immature oligodendrocyte progenitor cells.
Future studies will address the role of NF-kB signalling in
non-myelinating oligodendrocyte progenitor cells.
Most importantly, we demonstrate an essential pathogenic role
for brain-specific IKK2-dependent NF-kB signalling during
toxin-induced demyelination in vivo. The amelioration of demye-
lination in mice with brain-restricted NF-kB inhibition correlated
with impaired induction of inflammatory cytokines, which are
potentially toxic for oligodendrocytes. Despite the fact that
IKK2-mediated canonical NF-kB signalling is known to be involved
in the regulation of a plethora of effects, these findings suggest
that the mechanism by which inhibition of canonical NF-kB signal-
ling in the CNS mediates its myelin-protecting effect is by prevent-
ing the expression of proinflammatory mediators by CNS-resident
cells. However, since IKK2-mediated canonical activation of NF-kB
was described to be involved in the regulation of numerous factors
like chemokines, cell-adhesion molecules and other transcription
factors (www.NF-kB.org) (Perkins, 2007; Vallabhapurapu and
Karin, 2009), additional paradigms of the role of canonical
NF-kB signalling in the context of myelin-protection in the CNS
might be considered as well. Moreover, despite the fact that the
most prominent function of IKKb is allocated to the canonical acti-
vation of NF-kB (by phosphorylation of inhibitory molecules)
(Hayden and Ghosh, 2008), recent studies indicate that IKK2 is
also able to target/phosphorylate proteins independent of NF-kB
(Chariot, 2009). The growing list of target molecules includes sig-
nalling molecules such as 14-3-3b, (Gringhuis et al., 2005), as well
as transcription factors such as FOXO3a (Hu et al., 2004). Hence, a
potential influence of IKK2 dependent but NF-kB independent func-
tions in the context of de- and remyelination in the CNS, cannot be
completely excluded, and therefore require further investigation.
Which are the cells mediating oligodendrocyte damage during
demyelinating events? The plethora of brain endogenous
Figure 7 Selective downregulation of NF-kB activation in neuroectodermal significantly inhibits myelin loss. (A) Laser microdissection of
GFAP + astrocytes (upper row) and CD11b + microglia (lower row) from the lesion site in the corpus callosum after 5 weeks of cuprizone
treatment. Location of cells before (left) and after (right) microdissection. Scale bar = 50 mm. (B) Quantification of cytokine and chemokine
messenger RNA in microdissected astrocytes and microglia reveals IKK2-dependent suppression of gene induction in astrocytes.
Messenger RNA levels were normalized to b-actin and compared with untreated controls. Mean  SEM from at least three mice per group
are exhibited. *P50.05. (C) Histopathological analysis of myelin loss and accompanying gliosis in GFAP-IkBa-dn and wild-type (WT)
mice 5 weeks after cuprizone treatment. Sections were assessed for myelin damage by luxol fast blue (LFB) and for gliosis (immunostaining
for astrocytes by GFAP and for microglia by MAC-3, respectively). Neuropathological changes were quantified (below) and statistically
significant changes were marked with *P50.05. (D) Expression of demyelination-associated genes in the corpus callosum of
GFAP-IkBa-dn (black bars) and wild-type (white bars) animals during toxic demyelination. Data are expressed as mean  SEM of at
least four animals per group and significant changes are indicated *P50.05.
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cytokines and chemokines is produced by microglia and astrocytes
(Hanisch, 2002). However, microglial cells were not targeted by
the CNS-specific approach we used and we have demonstrated
unaltered NF-kB activation in microglia. Using GFAP-IkBa-dn
mice, we provide evidence that inactivation of NF-kB in astrocytes
protects from myelin loss, reduces the expression of proinflamma-
tory mediators and suppresses gliosis during cuprizone-induced
demyelination. These NF-kB-dependent processes initiated in
astrocytes are potentially responsible for subsequent activation of
other glial cells, especially microglia that could enhance myelin
loss. This is also supported by the fact that dissected microglia
from IKK2CNS-KO animals also showed decreased gene induction
of CCL3 and CXCL10 during toxic demyelination. NF-kB activa-
tion in astrocytes induces both detrimental and protective effects
on CNS recovery. For the beneficial effects, reactive astrocytes
have a protective role in brain ischaemia that is linked to changes
in glutamate transport important for neuronal restoration and the
control of glial gap junctions (Li et al., 2008). NF-kB activation in
astrocytes further leads to the synthesis of neurotrophins such as
nerve growth factor and brain derived neurotrophic factor that are
essential for neuronal survival (Zaheer et al., 2001). As for the
detrimental functions, astroglial NF-kB activation increases excito-
toxic brain injury, resulting in decreased neuroprotection (Acarin
et al., 2001). Further, NF-kB stimulation promotes the transition of
astrocytes to a substrate non-permissive to neurite outgrowth (de
Freitas et al., 2002). After spinal cord injury, astrocyte-specific
suppression of NF-kB signalling improves functional recovery
by modulation of proteoglycan expression and modulation of
the inflammatory response (Brambilla et al., 2005). Finally,
NF-kB-dependent expression of vascular cell adhesion protein-1
by astrocytes participates in autoimmune demyelination, which is
completely abolished in CNS-specific IKK-deficient mice (van Loo
et al., 2006). Collectively, these data point to an important role for
NF-kB in astroglial cells controlling brain damage. Importantly, the
majority of our data were obtained in specific mouse models of
toxic demyelination using either the copper chelator cuprizone or
lysolecithin. The value of these models for studying demyelination
is the high reproducibility and robustness of myelin damage allow-
ing accurate description of oligodendrocyte features during de-and
remyelination. Our experimental approach, however, does not
allow us to assess the specific contribution of antigen-specific T
lymphocytes to oligodendrocyte damage as found in the brains of
patients with multiple sclerosis or in its mouse model experimental
autoimmune encephalomyelitis. Although it is possible from our
own previous report that showed a pathogenic role of NF-kB in
neuroectodermal cells during experimental autoimmune enceph-
alomyelitis (van Loo et al., 2006), these findings have to be con-
firmed for their relevance in multiple sclerosis. Similarly, whether
oligodendrocyte loss is also IKK2-mediated in other demyelinating
diseases such as leukodystrophies has to be validated in the re-
spective models such as the twitcher murine model of Krabbe
disease and others.
In conclusion, our study highlights IKK2-dependent NF-kB
signalling as a key pathogenic pathway during toxic CNS demye-
lination, which could potentially be targeted to suppress
demyelination-associated diseases as well.
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